In this episode of the weekly Budget & Tax News podcast, managing editor and research fellow Jesse Hathaway talks about the U.S. Food and Drug Administration new “deeming regulations” for electronic cigarettes, which require e-cigarette manufacturers to submit their products through an arduous federal approval process.
Legislators have long attempted to reduce the negative health impacts of smoking through taxes, bans, and regulations. Some have tried to extend these same policies to electronic cigarettes or “e-cigarettes,” even though they contain no tobacco and are substantially less harmful than traditional cigarettes. This week, the Food and Drug Administration (FDA) unveiled new regulations placing electronic cigarettes under an avalanche of new rules requiring that they be approved as a new type of tobacco product — effectively treating them like traditional cigarettes.
No serious study has ever been produced by the FDA to conclude anything but the positive health benefits of vaporized nicotine products compared to smoking cigarettes. So the FDA’s new regulations in the name of protecting public health will actually achieve the opposite … which is sadly typical for government work these days.
Public Health England last in August of 2015 became the first national government agency to endorse e-cigarettes as safer options for current smokers. Its report also dispelled several bogus anti-tobacco claims. Why is it that e-Cigarettes are seen as life-savers by the UK Government, but condemned by the US? Find out why by checking this recent article of Wednesday, April 13, 2016.
Cigarette smoking has become significantly less popular in the U.S. over the past decade, it still remains a public-health scourge. Smoking accounts for more than 480,000 deaths every year in this country, or about one of every five death, according to the Centers for Disease Control and Prevention, while an additional 16 million Americans live with a smoking-related disease. Clearly more needs to be done to get Americans to quit smoking.
The FDA’s approval process takes years, and for thousands of terminally ill patients, those years may be the difference between life and death. Aware of the risks, many patients are nonetheless willing to try medicines and treatments that are still under investigation in clinical trials. For a significant number of these patients, the alternative is certain death.
TweetThe journal Addiction published a study on April 25, with seven international tobacco control experts compelling the U.S. Food and Drug Administration (FDA) to have an open mind regulating vaporized[…]
Controversy continues to rage over whether foods from plants modified with molecular genetic engineering techniques should have to be labeled as such. The battle has been fought for years in the media, Congress, state legislatures, federal courts and through referendum issues. Most mandatory-labeling proposals have failed, and none is currently in effect–for good reason: They fail every test–scientific, economic, legal and common sense. That hasn’t prevented the more ignorant and ideological legislators from continuing to try.
Last November, I discussed a Yale research finding that smoking increased significantly among teens aged 12-17 in states that banned e-cigarette sales to minors compared with states with no bans (here). Now this from researchers at Cornell University: “We document a concerning trend of cigarette smoking among adolescents increasing when [e-cigarettes] become more difficult to purchase.”
TweetThe Tomorrow’s Cures Today Foundation (TCTF) says FDA regulations deprive terminally ill patients and their family members of hope. In a video posted February 6, TCTF tells the story of[…]
The Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015 (RESULT Act) would fast-track drug and medical device applications through the Food and Drug Administration’s sluggish and costly approval process. The act would streamline new products already vetted by a government agency in another Organization for Economic Cooperation and Development nation with a proven record of providing safe medical devices and pharmaceutical products.
In its endless attempt to turn the country into one giant Weight Watchers meeting, the Obama Administration tucked away a little-known provision in the health care law that authorizes the FDA to force certain businesses to post the calorie count for every menu item.
Hosts Donny Kendal and John Nothdurft continue to explore the world of think tanks in episode #25 of the In The Tank Podcast. This weekly podcast features (as always) interviews, debates, roundtable discussions, stories, and light-hearted segments on a variety of topics on the latest news. The show is available for download as part of the Heartland Daily Podcast every Friday. Today’s podcast features work from the Georgia Public Policy Foundation, the Mercatus Center, and the Libertas Institute.
Bill Gates doesn’t believe that those who operate within the free market can ever be compelled to produce alternative fuel sources, so he suggests that the government spend untold millions on it instead.
In today’s edition of The Heartland Daily Podcast, Kenneth Artz, managing editor of Health Care News speaks with Jeff Stier. Stier s a Senior Fellow at the National Center for Public Policy Research in Washington D.C. where he heads its Risk Analysis Division. Stier joins Artz to discuss the FDA’s new food labeling law, a law which will require most food establishments in the United States to list calorie counts for their food items.
In today’s edition of The Heartland Daily Podcast, Kenneth Artz, managing editor of Health Care News speaks with Jeff Stier. Stier s a Senior Fellow at the National Center for Public Policy Research in Washington D.C. where he heads its Risk Analysis Division. Stier joins Artz to discuss the U.S. Food and Drug Administration’s defacto ban on trans fats.
In today’s edition of The Heartland Institute Daily Podcast, Kenneth Artz, managing editor of Health Care News speaks with Jeff Stier. Stier, a senior fellow at the National Center for Public Policy Research in Washington D.C., heads their risk analysis division. In this podcast, Artz and Stier discuss the U.S. Food and Drug Administration’s (FDA) proposed rule that would extend the agency’s authority over tobacco products to include e-cigarettes.
In today’s edition of The Heartland Daily Podcast, National Center for Policy Analysis health care policy expert Devon Herrick joins Managing Editor of Health Care News Kenneth Artz. Herrick and Artz discuss how the policies of the U.S. Food and Drug Administration (FDA) are needlessly driving up the cost of generic Drugs.